AstraZeneca has entered an exclusive licence agreement with Alteogen involving t...
Experts at the 2025 Clinical Trial Supply New England conference will discuss st...
The two simultaneous Incyte trials in HS saw more than 40% of patients on povorc...
Latigo has secured $150m in a Series funding round, which will be used to furthe...
While China has become a key country for global clinical trials, navigating regu...
GSK’s shingles vaccine Shingrix passed $1bn in sales last year as Curevo aims to...
Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipelin...
Opko Health and Entera Bio have announced a partnership and licence agreement to...
The EC has granted expanded approval to BMS' Breyanzi, to treat adults with rela...
AstraZeneca’s senior director in oncology data science outlined how the company ...
Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research an...
The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase II...
The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsych...
Insilico Medicine has completed a Series E round, raising $110m to progress the ...
NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken onc...
The two companies are merging after previously filing for bankruptcy due to opio...
